Corporate Banner
Satellite Banner
Technology Networks Header
Saturday, November 29, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
Zetasizer Helix Combines Dynamic Light Scattering and Raman Spectroscopy for Advanced Protein Structure Analysis
Tuesday, July 08, 2014
The new Zetasizer Helix from Malvern Instruments is a powerful tool for early stage biopharmaceutical development that enables the detailed study of mechanisms of protein aggregation.

Method Separates Oxidized Monoclonal Antibody (MAb) Species
Friday, July 04, 2014
Thermo Scientific™ ProPac™ HIC-10 column used to separate the papain fragments.

Mettler-Toledo’s Next Generation Checkweighers
Thursday, July 03, 2014
Deliver unparalleled weighing accuracy with high throughput.

Olink Bioscience Introduces a 92-protein Biomarker Panel
Wednesday, July 02, 2014
Proseek® Multiplex Inflammation I 96x96 for inflammatory diseases.

DynaPro® Plate Reader Optimizes Screening Process for Biotherapeutic Candidates
Wednesday, July 02, 2014
The high-throughput DynaPro Plate Reader utilizes dynamic light scattering to identify most promising mAb buffer conditions prior to extended stability testing.

Mettler-Toledo Safeline X-ray’s X36 Series Boosts Versatility
Saturday, June 28, 2014
Five times more sensitive to x-rays than traditional systems for enhanced quality control.

Sometimes it Just Has to Be Glass
Tuesday, June 24, 2014
With the cost-efficient filled and unfilled SPE glass columns as well as matching accessories LCTech simplifies the daily routine in laboratories.

New Webinar on Improving Process Development Timelines with Mini Bioreactors
Saturday, June 21, 2014
Details fermentation and bioprocessing data generated by ambr250.

Agilent Introduces Innovative LC Columns, Biocolumns
Saturday, June 21, 2014
New Glycan mapping and small-molecule Poroshell HPH columns target challenging biotherapeutic research, high-performance pH applications.

<< 3 4 5 6 7 8 9 >>
Showing Results 51 - 60 of 490
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
SELECTBIO Market Reports
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv